Evaluation of the pro-angiogenic effect of factor XIII in heterotopic mouse heart allografts and FXIII-deficient mice

Thrombosis and Haemostasis

Volumn 95, Issue 3, 2006, Pages 546-550

  Dardik, Rima ^a,d   Leor, Jonathan ^a,d   Skutelsky, Ehud ^a,d   Castel, David ^a,d   Holbova, Radka ^a,d   Schiby, Ginette ^a,d   Shaish, Aviv ^a,d   Dickneite, Gerhard ^b   Loscalzo, Joseph ^c   Inbal, Aida ^a,d  

^a SHEBA MEDICAL CENTER   (Israel)

^b ZLB Behring ^*  (Germany)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Angiogenesis; Factor XIII; Thrombospondin I

Indexed keywords

BLOOD CLOTTING FACTOR 8; MATRIGEL; MESSENGER RNA; PROTEIN C JUN; THROMBOSPONDIN 1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HEART TRANSPLANTATION; HEMOPHILIA A; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; ANIMALS, NEWBORN; COLLAGEN; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; EAR, EXTERNAL; FACTOR XIII; FACTOR XIII DEFICIENCY; FACTOR XIIIA; GRAFT SURVIVAL; HEART TRANSPLANTATION; LAMININ; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MODELS, ANIMAL; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOGLYCANS; PROTO-ONCOGENE PROTEINS C-JUN; RNA, MESSENGER; THROMBOSPONDIN 1; TRANSPLANTATION, HETEROTOPIC;

EID: 33645543811     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-06-0409     Document Type: Article

References (17)

1. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669-76.
2. Browder T, Folkman J, Pirie-Shephered S. The hemostatic system as a regulator of angiogenesis. J Biol Chem 2000; 275: 1521-4.
3. Muszbek L, Adany R, Mikkola H. Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function. Crit Rev Clin Lab Sci 1996;33: 357-421.
4. Greenberg CS, Birckbichler PJ, Rice RH.Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J. 1991;5:3071-7.
5. Dardik R, Solomon A, Loscalzo J, et al. Novel proangiogenic effect of factor XIII associated with suppression of thrombospondin 1 expression. Arterioscler Thromb Vase Biol 2003; 23:1472-7.
6. Lawler J. Thrombospondin-1as an endogenous inhibitor of angiogenesis and tumor growth. J Cell Mol Med 2002; 6: 1-12.
7. Dardik R, Loscalzo J, Eskaraev R, et al. Molecular mechanisms underlying the proangiogenic effect of factor XIII (FXIII). Arterioscler Thromb Vasc Biol 2005; 25: 526-32.
8. DejongV, Degeorges A, Filleur S, et al. The Wilms tumor gene product represses the transcription of thrombospondin 1 in response to overexpression of c-Jun. Oncogene 1999; 18: 3143-51.
9. Koseki-Kuno S, Yamakawa M, Dickneite G, et al. Factor XIII A subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriages. Blood 2003; 102:4410-2.
10. Inbal A, Lubetsky A, Krapp T, et al. Impaired wound healing in factor XIII deficient mice. Thromb Haemost 2005;94: 432-7.
11. Fey TA, Krause RA, Hsieh GC, et al. Improved methods for transplanting split-heart neonatal cardiac grafts into the ear pinna of mice and rats. J Pharmacol Toxicol Methods 1998; 39: 9-17.
12. Lauer P, Metzner HJ, Zettlmeissl G, et al. Targeted inactivation of the mouse locus encoding coagulation factor XIII-A: hemostatic abnormalities in mutant mice and characterization of the coagulation deficit. Thromb Haemost 2002; 88: 967-74.
13. Kim HS, Skurk C, Thomas SR, et al. Regulation of angiogenesis by glycogen synthase kinase-bbeta. J Biol Chem 2002; 277: 41888-96.
14. Kumar P, Amin MA, Harlow LA, et al. Src and phosphatidylinositol 3-kinase mediate soluble E-selectin-induced angiogenesis. Blood 2003; 101: 3960-8.
15. Iruela-Arispe ML, Lombardo M, Krutzsch HC, et al. Inhibition of angiogenesis by thrombospondin-1is mediated by 2 independent regions within the type 1 repeats. Circulation 1999; 100: 1423-31.
16. Jimenez B, Volpert OV, Crawford SE, et al. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med 2000; 6: 41-8.
17. Kilian O, Fuhrmann R, Alt V, et al. Plasma transglutaminase factor XIII induces microvessel ingrowth into biodegradable hydroxyapatite implants in rats. Biomaterials 2005; 26: 1819-27.